8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 18, 2018

 

 

AMN HEALTHCARE SERVICES, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-16753   06-1500476

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

12400 High Bluff Drive, Suite 100

San Diego, California 92130

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (866) 871-8519

NOT APPLICABLE

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Section 5 – Corporate Governance and Management

Item 5.07. Submission of Matters to a Vote of Security Holders.

(a)    On April 18, 2018, AMN Healthcare Services, Inc. (the “Company”) held its 2018 Annual Meeting of Shareholders (the “Annual Meeting”).

(b)    The following items of business were voted upon by the Company’s shareholders at the Annual Meeting:

 

  1. Each of the Board of Directors’ nominees for director was elected to serve until the next annual meeting of shareholders or until their successors are duly elected and qualified, by the vote set forth in the table immediately below:

 

Director

   For      Against      Abstain      Broker Non-Votes  

Mark G. Foletta

     42,064,904        577,670        17,390        2,719,672  

R. Jeffrey Harris

     41,846,544        796,302        17,118        2,719,672  

Michael M.E. Johns, M.D.

     41,779,512        862,712        17,740        2,719,672  

Martha H. Marsh

     42,319,048        327,882        13,034        2,719,672  

Susan R. Salka

     41,992,350        655,628        11,986        2,719,672  

Andrew M. Stern

     41,489,315        1,153,359        17,290        2,719,672  

Paul E. Weaver

     41,888,446        753,828        17,690        2,719,672  

Douglas D. Wheat

     41,620,173        1,022,171        17,620        2,719,672  

 

  2. The compensation of named executive officers was approved, on an advisory (non-binding) basis, by the vote set forth in the table immediately below:

 

For

  

Against

  

Abstain

  

Broker Non-Votes

39,856,499

   2,445,404    358,061    2,719,672

 

  3. The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018 was ratified by the vote set forth in the table immediately below:

 

For

  

Against

  

Abstain

  

Broker Non-Votes

44,014,029

   1,346,471    19,136    0

 

  4. Shareholders did not approve a proposal to lower the threshold necessary for shareholders to call a special meeting from 20% to 10% by the vote set forth in the table immediately below:

 

For

  

Against

  

Abstain

  

Broker Non-Votes

18,724,184

   23,868,879    66,901    2,719,672


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    AMN Healthcare Services, Inc.
Date: April 24, 2018     By:  

/s/ Susan R. Salka

      Susan R. Salka
      President & Chief Executive Officer